PD19-02 OUTCOMES FOLLOWING RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE II PATIENTS EXPERIENCING A LATE RELAPSE FOLLOWING UPFRONT PLATINUM BASED CHEMOTHERAPY

INTRODUCTION AND OBJECTIVE:Late relapse (LR) following complete response to upfront radiation or chemotherapy for clinical stage II germ cell tumor is rare occurring in only 1-5% of cases. It is ch...